Canada warns U.S. against drug import plans, citing shortage concerns

18 July 2019 - Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply ...

Read more →

Report on the current status of the use of real‐world data and real‐world evidence in drug development and regulation

10 July 2019 - Radically expanding use of real‐world data and real‐world evidence holds the potential to substantially impact drug development, ...

Read more →

Bev takes 14 pills a day. She's far from alone.

15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...

Read more →

In praise of studies that use more than one generic preference-based measure

12 July 2019 - Generic preference-based measures of health-related quality of life are widely used as outcome measures in cost-effectiveness and ...

Read more →

'We have a health care crisis': Democrats take aim after Trump abandons drug prices plan

14 July 2019 - US Democrats have lined up after US President Donald Trump abandoned a proposal to lower drug prices. ...

Read more →

How the FDA uses science to speed medical device innovation

11 July 2019 - The MDDT program streamlines the medical device development and review process. ...

Read more →

Mulhollands' Māori health inquiry submission to focus firmly on drug funding problems

14 July 2019 - Malcolm Muholland's wife Wiki Mulholland has advanced breast cancer. Malcolm Mullholland says the details of an ...

Read more →

Grassley: deal to lower drug prices moving forward 'very soon'

11 July 2019 - Senate Finance Committee Chairman Chuck Grassley (R-Iowa) said Thursday that he plans to advance a bipartisan ...

Read more →

Eton Pharmaceuticals provides update on EM-100 program

12 July 2019 - Eton Pharmaceuticals today announced that the U.S FDA provided Eton’s partner with a complete response letter relating ...

Read more →

Protecting PHARMAC and cancer treatment

13 July 2019 - The "postcode lottery", delays and other failings for cancer treatment need to be addressed. ...

Read more →

Early benefit assessment reveals weaknesses in the development of new drugs

11 July 2019 - Analysis of 216 AMNOG assessments in the BMJ / Proposals for more targeted drug development ...

Read more →

Janssen submits application to U.S. FDA seeking approval of new Darzalex (daratumumab) subcutaneous formulation

12 July 2019 - Submission inclusive of data from Phase 3 COLUMBA study presented at ASCO. ...

Read more →

Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults

12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

AstraZeneca Biopharma President talks drug rebates, pricing

11 July 2019 - Is pharma feeling the pressure now that PBM stocks are released from regulatory risk? ...

Read more →

Aimmune statement on ICER final report on AR101 for peanut allergy

11 July 2019 - Exclusion of long-term desensitization and patient quality-of-life data by ICER fails to recognize the full value AR101 ...

Read more →

NICE recommends innovative treatment for type 1 diabetes

12 July 2019 - It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin. ...

Read more →